丙型肝炎的最佳治疗动态和基于抽样的分析
Optimal Therapy of Hepatitis C Dynamics and Sampling Based Analysis
摘要:
我们研究了两种丙型肝炎病毒(HCV)动力学模型,一种是干扰素(IFN)单药治疗,另一种是IFN和利巴韦林联合治疗。使用最陡梯度法,通过定义最小化感染肝细胞水平、病毒体群体和药物副作用的目标泛函,确定两种模型的最佳治疗。两种模型的最佳治疗显示出高疗效的初始期,随后逐渐下降。高疗效期与感染肝细胞水平以及病毒载量的显著降低相一致,而在肝再生后通过恢复肝细胞水平,疗效下降。当成本系数变化时,只要副作用相对较小,高功效期不会显著改变。这表明在药物副作用最小的情况下,最佳治疗对模型参数的依赖性更高。我们使用拉丁超立方体抽样技术随机生成大量的患者场景(即模型参数集),并研究在已确定的最佳治疗下每个集的动态。结果显示,与单药治疗相比,联合治疗的应答者百分比增加(如病毒载量下降至检测水平以下所示)。为研究样本参数与病毒载量降至检测水平以下所需时间之间的相关性而进行的统计学检验显示,与感染肝细胞的死亡率存在强单调相关性,确定其为决定个体药物方案的重要因素。
英文摘要:
We examine two models for hepatitis C viral (HCV) dynamics, one for monotherapy with interferon (IFN) and the other for combination therapy with IFN and ribavirin. Optimal therapy for both the models is determined using the steepest gradient method, by defining an objective functional which minimizes the infected hepatocyte levels, virion population and the side-effects of the drug(s). The optimal therapy for both the models shows an initial period of high efficacy, followed by a gradual decline. The period of high efficacy coincides with a significant decrease in the infected hepatocyte levels as well as viral load, whereas the efficacy drops after liver regeneration through restored hepatocyte levels. The period of high efficacy is not altered significantly when the cost coefficients are varied, as long as the side effects are relatively small. This suggests a higher dependence of the optimal therapy on the model parameters in case of drugs with minimal side effects. We use the Latin hypercube sampling technique to randomly generate a large number of patient scenarios (i.e, model parameter sets) and study the dynamics of each set under the optimal therapy already determined. Results show an increase in the percentage of responders (as indicated by drop in viral load below detection levels) in case of combination therapy as compared to monotherapy. Statistical tests performed to study the correlations between sample parameters and the time required for the viral load to fall below detection level, show a strong monotonic correlation with the death rate of infected hepatocytes, identifying it to be an important factor in deciding individual drug regimens.
机构、总结、中文摘要均由AI分析而来,可能存在错误,请以论文正文为准。